אוקספה ישראל - עברית - Ministry of Health

אוקספה

abbott medical laboratories ltd - acid casein 5.9 g / 100 ml; artificial vanilla 116 mg / 100 ml - liquid - combinations of electrolytes - oxepa is clinically shown to modulate the inflammatory response in critically ill, mechanically ventilated patients. it is appropriate for patients who have sepsis, ali (acute lung injury), or ards (acute respiratory distress syndrome).

נובונורם  0.5 מג ישראל - עברית - Ministry of Health

נובונורם 0.5 מג

novo nordisk ltd., israel - repaglinide - טבליה - repaglinide 0.5 mg - repaglinide - repaglinide - treatment of type ii diabetes.

נובונורם 1 מג ישראל - עברית - Ministry of Health

נובונורם 1 מג

novo nordisk ltd., israel - repaglinide - טבליה - repaglinide 1 mg - repaglinide - repaglinide - treatment of type ii diabetes .

נובונורם 2 מג ישראל - עברית - Ministry of Health

נובונורם 2 מג

novo nordisk ltd., israel - repaglinide - טבליה - repaglinide 2 mg - repaglinide - repaglinide - treatment of type ii diabetes.

רפאגליניד טבע   0.5 מג ישראל - עברית - Ministry of Health

רפאגליניד טבע 0.5 מג

teva pharmaceutical industries ltd, israel - repaglinide - טבליה - repaglinide 0.5 mg - repaglinide - repaglinide - treatment of type ii diabetes.

רפאגליניד טבע   1 מג ישראל - עברית - Ministry of Health

רפאגליניד טבע 1 מג

teva pharmaceutical industries ltd, israel - repaglinide - טבליה - repaglinide 1 mg - repaglinide - repaglinide - treatment of type ii diabetes.

רפאגליניד טבע   2 מג ישראל - עברית - Ministry of Health

רפאגליניד טבע 2 מג

teva pharmaceutical industries ltd, israel - repaglinide - טבליה - repaglinide 2 mg - repaglinide - repaglinide - treatment of type ii diabetes.

הפאגם B ישראל - עברית - Ministry of Health

הפאגם b

tzamal bio-pharma ltd - hepatitis b immunoglobulin - תמיסה להזרקה - hepatitis b immunoglobulin 312 iu/ml - hepatitis b immunoglobulin - hepatitis b immunoglobulin - prevention of hepatitis b recurrence following liver transplantation : hepagam b is indicated for the prevetion of hepatitis b recurrence following liver transplantation in hbsag-positive liver transplant patients. hepagam b should be administered intravenously for this indication.postexposure prophylaxis : hepagam b is indicated for the treatment of acute exposure to blood containing hbsag perinatal exposure of infants born to hbsag-positive mothers sexual exposure to hbsag-positive persons and household exposure to persons with acute hbv infection in the following settings: acute exposure to blood containing hbsag following either parenteral exposure (needlestick bite sharps) direct mucous membrane contact (accidental splash) or oral ingestion (pipetting accident) involving hbsag - positive materials such as blood plasma or serum. perinatal exposure of infants born to hbsag-positive mothers infants born to mothers positive for hbsag with or without hbeag. perinatal exposure of infants born to hbsag-positive

סיי-בי-ואק 10 מקגמל ישראל - עברית - Ministry of Health

סיי-בי-ואק 10 מקגמל

scivac ltd, israel - hepatitis b vaccines - תרחיף להזרקה - hepatitis b vaccines 10 mcg/ml - hepatitis b, purified antigen - hepatitis b, purified antigen - for active immunization against hepatitis b virus. in high dose: it is indicated for imunization of neonates & children in highly endemic areas.

סיי-בי-ואק 2.5 מקג0.5 מל ישראל - עברית - Ministry of Health

סיי-בי-ואק 2.5 מקג0.5 מל

scivac ltd, israel - hepatitis b vaccines - תרחיף להזרקה - hepatitis b vaccines 2.5 mcg / 0.5 ml - hepatitis b, purified antigen - hepatitis b, purified antigen - for active immunization against hepatitis b virus. in high dose: it is indicated for immunization of neonates & children in highly endemic areas.